Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates δ-catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

DSpace/Manakin Repository

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates δ-catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

Citable link to this page

. . . . . .

Title: Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates δ-catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer
Author: Lu, Jian-Ping; Kim, Kwonseop; Case, Thomas C; Matusik, Robert J; Chen, Yan-hua; Nopparat, Jongdee; Lu, Qun; Zhang, Jiao; Wolfe, Michael S.

Note: Order does not necessarily reflect citation order of authors.

Citation: Lu, Jian-Ping, Jiao Zhang, Kwonseop Kim, Thomas C. Case, Robert J. Matusik, Yan-hua Chen, Michael Wolfe, Jongdee Nopparat, and Qun Lu. 2010. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer. Molecular Cancer 9:304.
Full Text & Related Files:
Abstract: Background: Neuronal synaptic junction protein δ-catenin (CTNND2) is often overexpressed in prostatic adenocarcinomas but the mechanisms of its activation are unknown. To address this question, we studied the hypothesis that Hes1, human homolog of Drosophila Hairy and enhancer of split (Hes) 1, is a transcriptional repressor of δ-catenin expression and plays an important role in molecular carcinogenesis. Results: We identified that, using a δ-catenin promoter reporter assay, Hes1, but not its inactive mutant, significantly repressed the upregulation of δ-catenin-luciferase activities induced by E2F1. Hes1 binds directly to the E-boxes on δ-catenin promoter and can reduce the expression of δ-catenin in prostate cancer cells. In prostate cancer CWR22-Rv1 and PC3 cell lines, which showed distinct δ-catenin overexpression, E2F1 and Hes1 expression pattern was altered. The suppression of Hes1 expression, either by γ-secretase inhibitors or by siRNA against Hes1, increased δ-catenin expression. γ-Secretase inhibition delayed S/G2-phase transition during cell cycle progression and induced cell shape changes to extend cellular processes in prostate cancer cells. In neuroendocrine prostate cancer mouse model derived allograft NE-10 tumors, δ-catenin showed an increased expression while Hes1 expression was diminished. Furthermore, E2F1 transcription was very high in subgroup of NE-10 tumors in which Hes1 still displayed residual expression, while its expression was only moderately increased in NE-10 tumors where Hes1 expression was completely suppressed. Conclusion: These studies support coordinated regulation of δ-catenin expression by both the activating transcription factor E2F1 and repressive transcription factor Hes1 in prostate cancer progression.
Published Version: doi:10.1186/1476-4598-9-304
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009707/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4768920

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters